Global Dental Membrane and Bone Graft Substitute Market, by Product Type (Dental Membranes, (Resorbable Membranes, Non-Resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Bovine Xenograft, Porcine Xenograft, Synthetic Bone Graft Substitutes)), by Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene), by End User (Hospitals, Dental Clinics, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,045.3 Million in 2022 and is expected to exhibit a CAGR of 9.4% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
The increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the dental membranes and bone graft substitutes market over the forecast period. For instance, in March 2022, Molecular Matrix, Inc., a biotechnology company, announced that they had launched Osteo-P synthetic bone graft substitute for use in musculoskeletal system and to optimize the microenvironment for bone repair and regeneration.
Global Dental Membranes and Bone Graft Substitutes Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a positive impact on the global dental membranes and bone graft substitutes market, owing to the increasing funding by the government. For instance, in February 2021, the department of Health of Northern Ireland announced the funding of US$ 2 million to help improve patient throughput at dental surgeries in Northern Ireland. As, due to COVID-19 the dental practices including dental surgeries, dental membrane substitutes have decreased. Hence, this funding will provide a financial support to the dental treatments and increase the demand for dental surgeries.
Global Dental Membranes and Bone Graft Substitutes Market: Key Developments
In February 2019, Medtronic, a medical device company, announced that they launched the Grafton(TM) Demineralized Bone Matrix (DBM), a bone grafting product use for spine and orthopedic procedures. Grafton DBM is a bone graft extender, bone graft substitute, and bone void filler in bony voids or gaps of the skeletal system. It is an osteoconductive material with osteoinductive capabilities that vary among different products, depending on donor characteristics and differences in processing of the bone.
Browse 35 Market Data Tables and 42 Figures spread through 170 Pages and in-depth TOC on “Global Dental Membranes and Bone Graft Substitutes Market”- Forecast to 2030, Global Dental Membranes and Bone Graft Substitutes Market, by Product Type (Dental Membranes, (Resorbable Membranes, Non-Resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Bovine Xenograft, Porcine Xenograft, Synthetic Bone Graft Substitutes)), by Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene), by End User (Hospitals, Dental Clinics, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
Moreover, increasing adoption of inorganic strategies by market players such as agreement is expected to drive the market over the forecast period. For instance, in September 2019, Molecular Matrix, Inc., a biotechnology company, announced that they had signed an agreement with Philosys Healthcare Co., Ltd., a medical device company. This agreement will expand the availability of a next-generation bone graft substitute technology for bone tissue regeneration.
Key Takeaways of the Global Dental Membranes and Bone Graft Substitutes Market:
- The global dental membranes and bone graft substitutes market is expected to exhibit a CAGR of 9.4% during the forecast period due to the increasing adoption of strategies such as product launches by the key market players. For instance, in April 2019, LASAK s.r.o., a manufacturer of dental implants, announced that they had launched the Collagene AT membrane which is a resorbable collagen membrane for effective wound healing and tissue regeneration. It is used primarily together with a bone substitute material, such as OssaBase-HA and PORESORB-TCP.
- Among product type, dental membranes segment is estimated to hold a dominant position in the global dental membranes and bone graft substitutes market due to increasing product launch by key market players over the forecast period. For instance, in September 2022, Matregenix, a MedTech company, announced that they have received a grant award from the National Institute of Dental & Craniofacial Research under the auspices of the Small Business Innovation Research program and National Institutes of Health. The grant will be utilized to develop a new dental barrier membrane for guided bone regeneration.
- Among regions, North America is estimated to account for the largest market share in the global dental membranes and bone graft substitutes market, owing to the increasing agreements. For instance, in March 2022 Biocomposites, a medical devices company and Zimmer Biomet, a global medical technology leader, announced that they have entered into a multi-year agreement to exclusively distribute genex bone graft substitute with its new mixing system and delivery options in the U.S. orthopaedic market.
- Major players operating in the global dental membranes and bone graft substitutes market include Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
